Short answer · Medically reviewed summary · Last updated: 2026-04-07
Ankylosing Spondylitis is a chronic inflammatory disease primarily caused by a complex interaction between genetic predisposition—most notably the presence of the HLA-B27 gene—and an overactive immune system response. While the exact trigger remains a subject of ongoing research, scientists believe environmental factors, such as microbiome changes or infections, likely initiate the inflammatory process in the skeletal system of genetically susceptible individuals. What exactly causes Ankylosing Spondylitis? The exact etiology of Ankylosing Spondylitis is not fully understood, but it is categorized as a systemic autoimmune condition.
18 people with Ankylosing Spondylitis have shared their first-person experience on this question at DiseaseMaps.
Ankylosing Spondylitis is a chronic inflammatory disease primarily caused by a complex interaction between genetic predisposition—most notably the presence of the HLA-B27 gene—and an overactive immune system response. While the exact trigger remains a subject of ongoing research, scientists believe environmental factors, such as microbiome changes or infections, likely initiate the inflammatory process in the skeletal system of genetically susceptible individuals.
The exact etiology of Ankylosing Spondylitis is not fully understood, but it is categorized as a systemic autoimmune condition. In Ankylosing Spondylitis, the immune system mistakenly attacks the entheses—the sites where ligaments and tendons attach to bone—leading to chronic inflammation. Over time, this inflammation can cause new bone growth, resulting in the fusion of vertebrae. Think of it as the body’s "repair" mechanism going into overdrive, attempting to heal inflammation by depositing excess bone, which eventually restricts movement and causes significant stiffness.
Genetics play a significant role in the development of Ankylosing Spondylitis. The most well-established genetic link is the HLA-B27 gene, which is found in approximately 85–90% of Caucasian patients with the condition. However, having the HLA-B27 gene does not guarantee that a person will develop Ankylosing Spondylitis; only about 5% of people who carry this gene actually go on to develop the disease. This suggests that while genetics provide the "blueprint" for susceptibility, other factors are required to "switch on" the condition.
Research into Ankylosing Spondylitis indicates that environmental triggers likely interact with genetic factors to initiate the disease. Current scientific focus areas include:
In medical research, a "cause" is a direct factor that initiates the disease, while a "risk factor" increases the likelihood of developing it. For Ankylosing Spondylitis, the HLA-B27 gene is a strong risk factor, but it is not a direct cause. Ongoing studies are investigating the role of the "gut-joint axis," exploring how the digestive system communicates with the immune system to potentially drive the disease. Researchers are also using advanced genomic sequencing to identify non-HLA-B27 genes that may contribute to the risk profile, helping us better understand why Ankylosing Spondylitis affects individuals so differently.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.